PRODUCTION OF HIGH-AFFINITY ANTIBODIES THROUGH THE IN VITRO RECREATION OF A GERMINAL CENTER

CSIC have developed a method for the in vitro generation of antigen-specific antibodies or cells producing thereof by means of the development of an in vitro germinal center useful to produce vaccines, immunomodulators or immunotherapies.
Industrial partners from the biotechnology and/or pharmaceutical industry are being sought to collaborate through a patent licence agreement.